skip to main content

H.R. 2416 (114th): To amend the Federal Food, Drug, and Cosmetic Act to evaluate the potential use of evidence from clinical experience to help support the approval of new indications for approved drugs, and for other purposes.

Cosponsors

none

Committee Assignments

Committee chairs determine whether a bill will move past the committee stage.

Votes

There have been no roll call votes related to this bill.

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

H.R. 34 (Related)
21st Century Cures Act

Enacted — Signed by the President
Dec 13, 2016

Search for similar bills.

Subject Areas